After Failed COVID-19 Drug Trial, Atea Pharmaceuticals Touts Encouraging Data From Mid-Stage Hepatitis C Study
Atea Pharmaceuticals(AVIR) Benzinga·2024-12-05 04:14Atea Pharmaceuticals(AVIR) Benzinga·2024-12-05 04:14
R1Atea Pharmaceuticals(AVIR) Benzinga·2024-12-05 04:14